… Our data show that remdesivir was superior to placebo in … oxygen and no longer requiring
ongoing medical care (used if … ongoing medical care (related to Covid-19 or to other medical …

… There were several instances where successful treatment of patients with this drug was
carried out as illustrated in this study. The small sample size from these observational studies …

… the most updated pharmacological treatments to effectively act … and future developments
in curing COVID-19 patients. … of 53 patients in whom it was possible to analyse the data (68…

… Our data show that remdesivir was superior to placebo in … oxygen and no longer requiring
ongoing medical care (used if … ongoing medical care (related to Covid-19 or to other medical …

… , one was suspended due to a lack of COVID‐19 patients to recruit. … treatment for people in
hospital with COVID‐19 and if it causes unwanted effects compared to placebo or usual care. …

… Clinical data of 135 COVID-19 patients were collected from 23 January 2020, when the first
case … data of patients using the electronic medical record system (HIS). General information …

… the medical records of 55 COVID-19 patients for analysis. We divided these patients into
mild… This is a retrospective study and we collected the medical records of 55 COVID-19 patients …

… data, and inclusion in the treatment protocols of COVID-19. … The current review provides
an overview of in-vitro data, dosing … trials and medical appraisal of favipiravir for COVID-19 is …

… We here summarize the current clinical characteristics data to guide potential COVID-19 …
survey, there are cases where patients confirmed with COVID-19 infection have no chest CT …

… This paper reviews the literature on all available information about the epidemiology, … In a
series of 51 patients with confirmed COVID-19 infection, 71% patients were RT-PCR positive at …